Tag: Obesity Treatment
-
India’s Doctors Sound Alarm Over Boom in Availability of Weight Loss Injections
Unregulated Rush for Weight Loss Injections India’s medical community is sounding the alarm over a rapidly expanding market for weight loss injections. While appetite-suppressing drugs have shown potential in clinical settings, doctors warn that an unregulated boom risks patient safety, long-term health consequences, and the misapplication of these treatments as a quick fix for obesity…
-
Wegovy Advances to PBS Listing: Semaglutide for Obesity and Heart Disease
Wegovy Moves Closer to PBS Listing Semaglutide, sold under the brand Wegovy, is nearing a pivotal milestone in Australia’s healthcare system. After preliminary recommendations from the Pharmaceutical Benefits Advisory Committee (PBAC), Wegovy could soon be available on the Pharmaceutical Benefits Scheme (PBS) for adults with established cardiovascular disease who also have obesity. This potential PBS…
-
Postpartum GLP-1 Drugs Use Among New Mothers Surges, Study Finds
Overview: A new trend in postpartum care Researchers from Denmark have identified a notable shift in how some women manage weight after pregnancy. The study, which tracked medication use among postpartum women, found a sharp increase in prescriptions for GLP-1 receptor agonists—commonly known as weight‑loss drugs such as Ozempic and Wegovy—beginning shortly after childbirth. This…
-
GLP-1 Medications and Pregnancy: Interpreting Early Signals and Risks
Understanding GLP-1 Medications and Pregnancy GLP-1 receptor agonists, such as Ozempic (semaglutide), are widely prescribed for type 2 diabetes and some cases of obesity treatment. They work by mimicking an incretin hormone that helps regulate blood sugar and appetite. When considering pregnancy, however, medical guidance has historically recommended avoiding GLP-1 medications because of potential risks…
-
GLP-1 Medications and Pregnancy: Early Signals, Important Caveats
Overview: GLP-1 Drugs and Pregnancy Concerns Glucagon-like peptide-1 (GLP-1) receptor agonists, including popular medications like Ozempic, are widely used to manage type 2 diabetes and support weight loss. Recent studies have raised questions about potential pregnancy-related risks for people taking these drugs. However, researchers stress that the data are preliminary, come with important caveats, and…
-
Overcoming Nausea: The Next Wave of Weight-Loss Drugs and Safer Experiences
Search for a ‘painless’ path to weight loss Millions of Americans have found success with prescription medications like Wegovy and Zepbound, which help reduce appetite and boost weight loss. Yet the journey isn’t the same for everyone. A common obstacle is nausea, a side effect that can range from mild discomfort to significant disruption in…
-
Brain scientists pursue nausea-free weight-loss drugs amid GLP-1 breakthroughs
Overview: The quest for nausea-free weight-loss medications Millions of Americans have achieved impressive weight loss with medications such as Wegovy and Zepbound, which target the body’s GLP-1 pathways to curb appetite and boost metabolic effects. Yet the journey with these drugs isn’t without rough edges. Nausea, vomiting, and other gastrointestinal side effects remain common early…
-
Brain scientists pursue nausea-free weight-loss drugs to improve outcomes
Overview: The quest for nausea-free weight-loss drugs Across the United States and beyond, millions have found success shedding pounds with medications such as Wegovy and Zepbound. These GLP-1 receptor agonists help reduce appetite and slow digestion, leading to meaningful weight loss for many individuals. Yet the journey isn’t without its rough edges. A sizable share…
-
Weight-loss injections: Real people, real journeys with Ozempic, Mounjaro and friends
Rising hope, rising costs: weight-loss injections in real lives Across Europe and beyond, prescription weight-loss medications have moved from clinical trials to everyday use. The stories of several adults—from small-business owners to healthcare workers and parents—highlight a common thread: these drugs can dramatically alter health, mindset, and daily routines, but they come with costs, side…
-
Ketone Supplement Lets Weight-Loss Drugs Protect Muscle
New approach aims to safeguard lean muscle during weight-loss therapy Researchers at the University of Alberta have found that a simple ketone ester supplement could tune weight-loss drugs to preserve lean muscle while still shedding fat. The study centers on semaglutide — the active ingredient in popular drugs like Ozempic, Wegovy and Rybelsus — and…